Conditions: Obsessive-Compulsive Disorder (OCD)
Keywords: OCD
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 7
Healthy volunteers: no

Brief summary:
This research study tests whether GLYX-13 - an experimental drug that acts on a brain receptor called NMDA - can decrease symptoms of OCD within hours. This is not a treatment study. Results from this study will allow doctors and researchers to better understand if you and others with OCD may respond to a class of medications that target the NMDA brain receptor.

Detailed description:

Arms:
arm 1: 10 mg/kg IV Rapastinel (formerly GLYX-13) infusion followed by assessments daily for a week, and weekly for a week.

Interventions: intervention 1: Rapastinel (formerly GLYX-13)
Intervention descriptions: intervention 1: 10 mg/kg IV Rapastinel (formerly GLYX-13)

Protocol document: